Download PDF
CC BY-NC-ND 4.0 · Indian J Radiol Imaging 2022; 32(02): 213-223
DOI: 10.1055/s-0042-1744520
Review Article

Imaging Tips and Tricks in Management of Renal and Urothelial Malignancies

Shanti Ranjan Sanyal
1   Department of Radiology, Royal Preston Hospital, Preston, United Kingdom
,
Ankur Arora
2   Department of Radiology, Royal Liverpool and Broadgreen University Hospitals NHS Trusst, Liverpool, United Kingdom
,
Amin Nisreen
1   Department of Radiology, Royal Preston Hospital, Preston, United Kingdom
,
Khattab Mohamed
1   Department of Radiology, Royal Preston Hospital, Preston, United Kingdom
,
Saeed Kilani Mohammad
1   Department of Radiology, Royal Preston Hospital, Preston, United Kingdom
,
Deb Baruah
3   Department of Radiology, Tezpur Medical College, Assam, India
› Author Affiliations Funding The authors declare no funding was obtained for this paper.
› Further Information
Also available at
   Permissions and Reprints

Abstract

Management of urological malignancies has evolved significantly with continually changing guidelines and treatment options which demand more centralized involvement of radiology than ever before.

Radiologists play a pivotal role in interpreting complex cancer scans and guiding clinical teams toward the best management options in the light of clinical profile. Management of complex uro-oncology cases is often discussed in multidisciplinary meetings which are essential checkpoints to evaluate an overall picture and formulate optimal treatment plans.

The aim of this article is to provide a radiological perspective with practical guidance to fellow radiologists participating in uro-oncology multidisciplinary meetings based on commonly encountered case scenarios, updated guidelines, and cancer pathways.

Crucial imaging tips with regards to renal and urinary tract cancers, upon which therapeutic decisions are made, have been condensed in this article after reviewing several complex cases from urology multidisciplinary meetings and European Association of Urology guidelines.

Outline of various diagnostic and management strategies, key staging features, surveillance guidelines, and, above all, what the onco-urologists want to know from radiologists have been succinctly discussed in this article.

Keywords

renal masses - urinary tract - imaging tips - surveillance - management

Availability of Data and Materials

Not applicable.


Ethics Approval and Consent to Participate

Not applicable.




Publication History

Article published online:
05 July 2022

© 2022. Indian Radiological Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • Refrences

  • 1 Wah TM. Image-guided ablation of renal cell carcinoma. Clin Radiol 2017; 72 (08) 636-644
    CrossrefPubMedSearch in Google Scholar
  • 2 Israel GM, Bosniak MA. Pitfalls in renal mass evaluation and how to avoid them. Radiographics 2008; 28 (05) 1325-1338
    CrossrefPubMedSearch in Google Scholar
  • 3 Prasad SR, Humphrey PA, Catena JR. et al. Common and uncommon histologic subtypes of renal cell carcinoma: imaging spectrum with pathologic correlation. Radiographics 2006; 26 (06) 1795-1806 , discussion 1806–1810
    CrossrefPubMedSearch in Google Scholar
  • 4 Childs DD, Clingan MJ, Zagoria RJ. et al. In-phase signal intensity loss in solid renal masses on dual-echo gradient-echo MRI: association with malignancy and pathologic classification. AJR Am J Roentgenol 2014; 203 (04) W421-W428
    CrossrefPubMedSearch in Google Scholar
  • 5 Uzzo RG, Novick AC. Nephron sparing surgery for renal tumors: indications, techniques and outcomes. J Urol 2001; 166 (01) 6-18
    CrossrefPubMedSearch in Google Scholar
  • 6 Narayanasamy S, Krishna S, Prasad Shanbhogue AK. et al. Contemporary update on imaging of cystic renal masses with histopathological correlation and emphasis on patient management. Clin Radiol 2019; 74 (02) 83-94
    CrossrefPubMedSearch in Google Scholar
  • 7 Przybycin CG, Magi-Galluzzi C, McKenney JK. Hereditary syndromes with associated renal neoplasia: a practical guide to histologic recognition in renal tumor resection specimens. Adv Anat Pathol 2013; 20 (04) 245-263
    CrossrefPubMedSearch in Google Scholar
  • 8 Bratslavsky G, Liu JJ, Johnson AD. et al. Salvage partial nephrectomy for hereditary renal cancer: feasibility and outcomes. J Urol 2008; 179 (01) 67-70
    CrossrefPubMedSearch in Google Scholar
  • 9 Neuzillet Y, Tillou X, Mathieu R. et al; Comité de Transplantation de l'Association Française d'Urologie, Comité de Cancérologie de l'Association Française d'Urologie. Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population. Eur Urol 2011; 60 (02) 366-373
    CrossrefPubMedSearch in Google Scholar
  • 10 Shannon BA, Cohen RJ, de Bruto H, Davies RJ. The value of preoperative needle core biopsy for diagnosing benign lesions among small, incidentally detected renal masses. J Urol 2008; 180 (04) 1257-1261 , discussion 1261
    CrossrefPubMedSearch in Google Scholar
  • 11 Haferkamp A, Bastian PJ, Jakobi H. et al. Renal cell carcinoma with tumor thrombus extension into the vena cava: prospective long-term followup. J Urol 2007; 177 (05) 1703-1708
    CrossrefPubMedSearch in Google Scholar
  • 12 Neves RJ, Zincke H. Surgical treatment of renal cancer with vena cava extension. Br J Urol 1987; 59 (05) 390-395
    CrossrefPubMedSearch in Google Scholar
  • 13 Flanigan RC, Mickisch G, Sylvester R, Tangen C, Van Poppel H, Crawford ED. Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis. J Urol 2004; 171 (03) 1071-1076
    CrossrefPubMedSearch in Google Scholar
  • 14 Miles KA, London NJ, Lavelle JM, Messios N, Smart JG. CT staging of renal carcinoma: a prospective comparison of three dynamic computed tomography techniques. Eur J Radiol 1991; 13 (01) 37-42
    CrossrefPubMedSearch in Google Scholar
  • 15 Capitanio U, Becker F, Blute ML. et al. Lymph node dissection in renal cell carcinoma. Eur Urol 2011; 60 (06) 1212-1220
    CrossrefPubMedSearch in Google Scholar
  • 16 Persigehl T, Lennartz S, Schwartz LH. iRECIST: how to do it. Cancer Imaging 2020; 20: 2
    CrossrefPubMedSearch in Google Scholar
  • 17 Wood EL, Adibi M, Qiao W. et al. Local tumor bed recurrence following partial nephrectomy in patients with small renal masses. J Urol 2018; 199 (02) 393-400
    CrossrefPubMedSearch in Google Scholar
  • 18 Skolarikos A, Alivizatos G, Laguna P, de la Rosette J. A review on follow-up strategies for renal cell carcinoma after nephrectomy. Eur Urol 2007; 51 (06) 1490-1500 , discussion 1501
    CrossrefPubMedSearch in Google Scholar
  • 19 Rutherford EE, Cast JEI, Breen DJ. Immediate and long-term CT appearances following radiofrequency ablation of renal tumours. Clin Radiol 2008; 63 (02) 220-230
    CrossrefPubMedSearch in Google Scholar
  • 20 Lee EK, Dickstein RJ, Kamta AM. Imaging of urothelial cancers: what the urologist needs to know. AJR Am J Roentgenol 2011; 196 (06) 1249-1254
    CrossrefPubMedSearch in Google Scholar
  • 21 Honda Y, Nakamura Y, Teishima J. et al. Clinical staging of upper urinary tract urothelial carcinoma for T staging: review and pictorial essay. Int J Urol 2019; 26 (11) 1024-1032
    CrossrefPubMedSearch in Google Scholar
  • 22 Cowan NC, Turney BW, Taylor NJ, McCarthy CL, Crew JP. Multidetector computed tomography urography for diagnosing upper urinary tract urothelial tumour. BJU Int 2007; 99 (06) 1363-1370
    CrossrefPubMedSearch in Google Scholar
  • 23 Browne RF, Meehan CP, Colville J, Power R, Torreggiani WC. Transitional cell carcinoma of the upper urinary tract: spectrum of imaging findings. Radiographics 2005; 25 (06) 1609-1627
    CrossrefPubMedSearch in Google Scholar
  • 24 Prando A, Prando P, Prando D. Urothelial cancer of the renal pelvicaliceal system: unusual imaging manifestations. Radiographics 2010; 30 (06) 1553-1566
    CrossrefPubMedSearch in Google Scholar
  • 25 Mohapatra A, Vemana G, Bhayani S, Baty J, Vetter J, Strope SA. Trends in the utilization of imaging for upper tract urothelial carcinoma. Urol Oncol 2016; 34 (05) 236.e23-236.e28
    CrossrefPubMedSearch in Google Scholar
  • 26 Leow JJ, Chong KT, Chang SL, Bellmunt J. Upper tract urothelial carcinoma: a different disease entity in terms of management. ESMO Open 2017; 1 (06) e000126-e000130
    CrossrefPubMedSearch in Google Scholar
  • 27 Xylinas E, Rink M, Cha EK. et al; Upper Tract Urothelial Carcinoma Collaboration. Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma. Eur Urol 2014; 65 (01) 210-217
    CrossrefPubMedSearch in Google Scholar
  • 28 Wong-You-Cheong JJ, Woodward PJ, Manning MA, Sesterhenn IA. From the archives of the AFIP: neoplasms of the urinary bladder: radiologic-pathologic correlation. Radiographics 2006; 26 (02) 553-580
    CrossrefPubMedSearch in Google Scholar
  • 29 Herr HW, Donat SM, Reuter VE. Management of low grade papillary bladder tumors. J Urol 2007;178(4, Pt 1):1201–1205, discussion 1205
  • 30 Brauers A, Buettner R, Jakse G. BrauersA. Second resection and prognosis of primary high risk superficial bladder cancer: is cystectomy often too early?. J Urol 2001; 165 (03) 808-810
    CrossrefPubMedSearch in Google Scholar
  • 31 Verma S, Rajesh A, Prasad SR. et al. Urinary bladder cancer: role of MR imaging. Radiographics 2012; 32: 371-387
    CrossrefPubMedSearch in Google Scholar
  • 32 Rajesh A, Sokhi HK, Fung R, Mulcahy KA, Bankart MJ. Bladder cancer: evaluation of staging accuracy using dynamic MRI. Clin Radiol 2011; 66 (12) 1140-1145
    CrossrefPubMedSearch in Google Scholar
  • 33 Svatek RS, Clinton TN, Wilson CA. et al. Intravesical tumor involvement of the trigone is associated with nodal metastasis in patients undergoing radical cystectomy. Urology 2014; 84 (05) 1147-1151
    CrossrefPubMedSearch in Google Scholar
  • 34 Millán-Rodríguez F, Chéchile-Toniolo G, Salvador-Bayarri J, Huguet-Pérez J, Vicente-Rodríguez J. Upper urinary tract tumors after primary superficial bladder tumors: prognostic factors and risk groups. J Urol 2000; 164 (04) 1183-1187
    CrossrefPubMedSearch in Google Scholar
  • 35 Stein JP, Lieskovsky G, Cote R. et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 2001; 19 (03) 666-675
    CrossrefPubMedSearch in Google Scholar
  • 36 Kundra V, Silverman PM. Imaging in oncology from the University of Texas M. D. Anderson Cancer Center. Imaging in the diagnosis, staging, and follow-up of cancer of the urinary bladder. AJR Am J Roentgenol 2003; 180 (04) 1045-1054
    CrossrefPubMedSearch in Google Scholar
  • 37 Sagebiel TL, Viswanathan C, Patnana M, Devine CE, Frumovitz M, Bhosale PR. Overview of the role of imaging in pelvic exenteration. Radiographics 2015; 35 (04) 1286-1294
    CrossrefPubMedSearch in Google Scholar
  • 38 Swinnen G, Maes A, Pottel H. et al. FDG-PET/CT for the preoperative lymph node staging of invasive bladder cancer. Eur Urol 2010; 57 (04) 641-647
    CrossrefPubMedSearch in Google Scholar
  • 39 Nieuwenhuijzen JA, de Vries RR, Bex A. et al. Urinary diversions after cystectomy: the association of clinical factors, complications and functional results of four different diversions. Eur Urol 2008; 53 (04) 834-842 , discussion 842–844
    CrossrefPubMedSearch in Google Scholar
  • 40 Picozzi S, Ricci C, Gaeta M. et al. Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185 patients. J Urol 2012; 188 (06) 2046-2054
    CrossrefPubMedSearch in Google Scholar
  • 41 Madersbacher S, Schmidt J, Eberle JM. et al. Long-term outcome of ileal conduit diversion. J Urol 2003; 169 (03) 985-990
    CrossrefPubMedSearch in Google Scholar
  • 42 Cagiannos I, Morash C. Surveillance strategies after definitive therapy of invasive bladder cancer. Can Urol Assoc J 2009; 3 (6, Suppl 4): S237-S242
    CrossrefPubMedSearch in Google Scholar